001     298944
005     20250223015325.0
024 7 _ |a 10.1136/bmjopen-2024-085456
|2 doi
024 7 _ |a pmid:39956597
|2 pmid
024 7 _ |a pmc:PMC11831281
|2 pmc
024 7 _ |a altmetric:174303934
|2 altmetric
037 _ _ |a DKFZ-2025-00378
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Prue, Gillian
|b 0
245 _ _ |a Models of care and associated targeted implementation strategies for cancer survivorship support in Europe: a scoping review protocol.
260 _ _ |a London
|c 2025
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1739889959_9494
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Delivery of Health Care, Integrated
|2 Other
650 _ 7 |a Health Services
|2 Other
650 _ 7 |a Health policy
|2 Other
650 _ 7 |a International health services
|2 Other
650 _ 7 |a Patient-Centered Care
|2 Other
650 _ 7 |a Review
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Europe
|2 MeSH
650 _ 2 |a Cancer Survivors
|2 MeSH
650 _ 2 |a Neoplasms: therapy
|2 MeSH
650 _ 2 |a Research Design
|2 MeSH
650 _ 2 |a Survivorship
|2 MeSH
700 1 _ |a Czamanski-Cohen, Johanna
|b 1
700 1 _ |a Kassianos, Angelos P
|b 2
700 1 _ |a Pilleron, Sophie
|0 0000-0001-7146-4740
|b 3
700 1 _ |a Ladas, Aristea
|b 4
700 1 _ |a Akcakaya Can, Aysun
|b 5
700 1 _ |a Roldán-Jiménez, Cristina
|0 0000-0002-7355-9740
|b 6
700 1 _ |a Degi, Csaba Laszlo
|b 7
700 1 _ |a Işcan, Gökçe
|b 8
700 1 _ |a Arslan, Sevban
|b 9
700 1 _ |a de Boer, Angela G E M
|b 10
700 1 _ |a Celebic, Aleksandar
|b 11
700 1 _ |a Doñate-Martínez, Ascensión
|b 12
700 1 _ |a Alhambra-Borrás, Tamara
|b 13
700 1 _ |a Mitrevski, Boce
|b 14
700 1 _ |a Marzorati, Chiara
|b 15
700 1 _ |a Pravettoni, Gabriella
|b 16
700 1 _ |a Grasso, Roberto
|b 17
700 1 _ |a Nazik, Evsen
|b 18
700 1 _ |a Pawlowska, Ewa
|b 19
700 1 _ |a Mucalo, Iva
|b 20
700 1 _ |a Browne, John Patrick
|b 21
700 1 _ |a Tripkovic, Katica
|b 22
700 1 _ |a Vojvodic, Katarina
|b 23
700 1 _ |a Karekla, Maria
|b 24
700 1 _ |a Moschofidou, Maria
|b 25
700 1 _ |a Bayram, Sule Biyik
|b 26
700 1 _ |a Brandão, Tânia
|b 27
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 28
|u dkfz
700 1 _ |a Jaswal, Poonam
|b 29
700 1 _ |a Semerci, Remziye
|b 30
700 1 _ |a Bozkul, Gamze
|b 31
700 1 _ |a Sahin, Eda
|b 32
700 1 _ |a Toygar, Ismail
|b 33
700 1 _ |a Frountzas, Maximos
|b 34
700 1 _ |a Martins, Rui Miguel
|b 35
700 1 _ |a Jefford, Michael
|b 36
700 1 _ |a Keane, Danielle
|0 0000-0002-2355-2567
|b 37
700 1 _ |a Hegarty, Josephine
|b 38
773 _ _ |a 10.1136/bmjopen-2024-085456
|g Vol. 15, no. 2, p. e085456 -
|0 PERI:(DE-600)2599832-8
|n 2
|p e085456
|t BMJ open
|v 15
|y 2025
|x 2044-6055
909 C O |o oai:inrepo02.dkfz.de:298944
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BMJ OPEN : 2022
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-01-24T13:10:16Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-01-24T13:10:16Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
|d 2024-01-24T13:10:16Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-19
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-19
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-19
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l C071 Cancer Survivorship
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21